The effect of local heat therapy on chest pain

The effect of local heat therapy in the posterior of chest on chest paincardiovascular function in patients with acute coronary syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015081312878N2

Enrollment

Registered

2015-09-16

Start date

2015-08-26

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrom. Ischaemic heart diseases

Interventions

Intervention 1: Patients in the experimental groups will be received local heat therapy in the posterior of chest using a hot pack warmed to 50°C. Intervention 2: Patients in the placebo groups will

Patients in the experimental groups will be received local heat therapy in the posterior of chest using a hot pack warmed to 50°C

Patients in the placebo groups will be received local heat therapy in the posterior of chest using a hot pack warmed 37 °C

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: The existence of absolute diagnosis of acute coronary syndrome by the specialist physician, having a stable physiological condition for answering to questions, age range from 18 to 100, non addiction to alcohol and narcotics, having no diabetic or muscloskeletal disease of chest or digestive diseases at the time of the disease, no existence of inflammation, wound, scratching and redness in the area of chest. Exclusion criteria: Lock of tendency to participate in the study, worsening the patients condition and lack of a stable condition for answering the questions and every type of clinical condition that requires a special diagnosis and treatment that local heat therapy for the patient be impossible.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Chest pain. Timepoint: Befor and after intervention. Method of measurement: McGill Pain Questionnaire.	—

Secondary

Measure	Time frame
Heart rate. Timepoint: Befor and after intervention. Method of measurement: Heart rate (beats/min) will be measured with cardiac monitor.;Systolic BP. Timepoint: Befor and after intervention. Method of measurement: Systolic pressure (mmhg) will be measured with cardiac monitor.;Diastolic BP. Timepoint: Befor and after intervention. Method of measurement: Diastolic pressure (mmhg) will be measured with cardiac monitor.;O2saturation. Timepoint: Befor and after intervention. Method of measurement: Pulse oximetry.	—

Measure

Time frame

Heart rate. Timepoint: Befor and after intervention. Method of measurement: Heart rate (beats/min) will be measured with cardiac monitor.;Systolic BP. Timepoint: Befor and after intervention. Method of measurement: Systolic pressure (mmhg) will be measured with cardiac monitor.;Diastolic BP. Timepoint: Befor and after intervention. Method of measurement: Diastolic pressure (mmhg) will be measured with cardiac monitor.;O2saturation. Timepoint: Befor and after intervention. Method of measurement: Pulse oximetry.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBatol Mohammadian

Gonabad University of Medical Science

mohammadian.b@gmu.ac.ir+98 51 5722 3028

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026